RESPONSE TO MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE IN 108 PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA AND NO PRIOR CHEMOTHERAPY

被引：243
作者：
ELIAS, A
RYAN, L
SULKES, A
COLLINS, J
AISNER, J
ANTMAN, KH
机构：
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT,BOSTON,MA 02115
[2] UNIV MARYLAND,CTR CANC,DEPT ONCOL,BALTIMORE,MD 21201
[3] NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 09期
关键词：
D O I：
10.1200/JCO.1989.7.9.1208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1208 / 1216
页数：9
相关论文
共 56 条
[1]  
ALLEN LM, 1975, CLIN PHARMACOL THER, V17, P492
[2]  
ANTMAN K, 1989, CANCER PRINCIPLES PR, P1345
[3]   RESPONSE TO IFOSFAMIDE AND MESNA - 124 PREVIOUSLY TREATED PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA [J].
ANTMAN, KH ;
RYAN, L ;
ELIAS, A ;
SHERMAN, D ;
GRIER, HE .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :126-131
[4]   CHEMOTHERAPY OF ADVANCED SOFT-TISSUE SARCOMAS [J].
ANTMAN, KH ;
ELIAS, AD .
SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (01) :53-58
[5]  
ANTMAN KH, 1985, CANCER TREAT REP, V69, P499
[6]  
BAKER L, 1987, P AN M AM SOC CLIN, V6, P138
[7]   COMBINATION CHEMOTHERAPY USING ADRIAMYCIN, DTIC, CYCLOPHOSPHAMIDE, AND ACTINOMYCIN-D FOR ADVANCED SOFT-TISSUE SARCOMAS - A RANDOMIZED COMPARATIVE TRIAL - A PHASE-III, SOUTHWEST-ONCOLOGY-GROUP-STUDY (7613) [J].
BAKER, LH ;
FRANK, J ;
FINE, G ;
BALCERZAK, SP ;
STEPHENS, RL ;
STUCKEY, WJ ;
RIVKIN, S ;
SAIKI, J ;
WARD, JH .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) :851-861
[8]   GRADE-3 NAUSEA, VOMITING, AND MYELOSUPPRESSION OR PROGRESSIVE, METASTATIC SARCOMA [J].
BENJAMIN, RS .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) :833-835
[9]   CHEMOTHERAPY IN ADVANCED SARCOMAS [J].
BIERBAUM, W ;
BREMER, K ;
FIRUSIAN, N ;
HIGI, M ;
NIEDERLE, N ;
SCHEULEN, ME ;
SCHMIDT, CG ;
SEEBER, S .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1981, 106 (37) :1181-&
[10]  
BODEY GP, 1981, CANCER, V47, P2422, DOI 10.1002/1097-0142(19810515)47:10<2422::AID-CNCR2820471017>3.0.CO
123456